{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:16:32Z","timestamp":1775682992615,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,7]]},"DOI":"10.7759\/cureus.15506","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T21:40:43Z","timestamp":1623102043000},"source":"Crossref","is-referenced-by-count":4,"title":["Ropinirole-Associated Orthostatic Hypotension as Cause of a Prescribing Cascade in an Elderly Man"],"prefix":"10.7759","author":[{"given":"Ana F","family":"Becerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Boch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahya A","family":"Al-Mezrakchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15543","article-title":"What is known about preventing, detecting, and reversing prescribing cascades: a scoping review","volume":"66","author":"Brath H","year":"2018","unstructured":"Brath H, Mehta N, Savage RD, et al.. What is known about preventing, detecting, and reversing prescribing cascades: a scoping review. J Am Geriatr Soc. 2018, 66:2079-2085. 10.1111\/jgs.15543","journal-title":"J Am Geriatr Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31188-1","article-title":"The prescribing cascade revisited","volume":"389","author":"Rochon P","year":"2017","unstructured":"Rochon P, Gurwitz J. The prescribing cascade revisited. The Lancet. 2017, 389:1778-1780. 10.1016\/S0140-6736(17)31188-1","journal-title":"The Lancet"},{"key":"ref3","article-title":"Ropinirole","author":"Rewane A","year":"2021","unstructured":"Rewane A, Nagalli S. Ropinirole. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00171","article-title":"Restless legs syndrome: from pathophysiology to clinical diagnosis and management","volume":"9","author":"Guo S","year":"2017","unstructured":"Guo S, Huang J, Jiang H, et al.. Restless legs syndrome: from pathophysiology to clinical diagnosis and management. Front Aging Neurosci. 2017, 9:171. 10.3389\/fnagi.2017.00171","journal-title":"Front Aging Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2009.07.008","article-title":"Behavioral sleep medicine interventions for restless legs syndrome and periodic limb movement disorder","volume":"4","author":"Pigeon WR","year":"2009","unstructured":"Pigeon WR, Yurcheshen M. Behavioral sleep medicine interventions for restless legs syndrome and periodic limb movement disorder. Sleep Med Clin. 2009, 4:487-494. 10.1016\/j.jsmc.2009.07.008","journal-title":"Sleep Med Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-013-0241-x","article-title":"Treatment of restless legs syndrome","volume":"15","author":"Romenets SR","year":"2013","unstructured":"Romenets SR, Postuma RB. Treatment of restless legs syndrome. Curr Treat Options Neurol. 2013, 15:396-409. 10.1007\/s11940-013-0241-x","journal-title":"Curr Treat Options Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/nedt.2006.2.4.407","article-title":"Ropinirole for the treatment of restless legs syndrome","volume":"2","author":"Kushida CA","year":"2006","unstructured":"Kushida CA. Ropinirole for the treatment of restless legs syndrome. Neuropsychiatr Dis Treat. 2006, 2:407-419. 10.2147\/nedt.2006.2.4.407","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003388","article-title":"Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"87","author":"Winkelman JW","year":"2016","unstructured":"Winkelman JW, Armstrong MJ, Allen RP, et al.. Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2016, 87:2585-2593. 10.1212\/WNL.0000000000003388","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.1988","article-title":"The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline","volume":"35","author":"Aurora RN","year":"2012","unstructured":"Aurora RN, Kristo DA, Bista SR, et al.. The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012, 35:1039-1062. 10.5665\/sleep.1988","journal-title":"Sleep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.10.1461","article-title":"Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease","volume":"57","author":"Kujawa K","year":"2000","unstructured":"Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000, 57:1461-1463. 10.1001\/archneur.57.10.1461","journal-title":"Arch Neurol"},{"key":"ref11","article-title":"Polypharmacy: a global risk factor for elderly people","volume":"6","author":"Dagli RJ","year":"2014","unstructured":"Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int Oral Health. 2014, 6:i-ii.","journal-title":"J Int Oral Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00064","article-title":"The management of orthostatic hypotension in Parkinson's disease","volume":"4","author":"S\u00e1nchez-Ferro A","year":"2013","unstructured":"S\u00e1nchez-Ferro A, Benito-Le\u00f3n J, G\u00f3mez-Esteban JC. The management of orthostatic hypotension in Parkinson's disease. Front Neurol. 2013, 4:64. 10.3389\/fneur.2013.00064","journal-title":"Front Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1715163516640811","article-title":"Prescribing cascade in an elderly woman","volume":"149","author":"Nguyen PV","year":"2016","unstructured":"Nguyen PV, Spinelli C. Prescribing cascade in an elderly woman. Can Pharm J (Ott). 2016, 149:122-124. 10.1177\/1715163516640811","journal-title":"Can Pharm J (Ott)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2010.01494.x","article-title":"Potentially inappropriate prescribing in elderly: assessing doctor knowledge, confidence and barriers","volume":"17","author":"Ramaswamy R","year":"2011","unstructured":"Ramaswamy R, Maio V, Diamond JJ, Talati AR, Hartmann CW, Arenson C, Roehl B. Potentially inappropriate prescribing in elderly: assessing doctor knowledge, confidence and barriers. J Eval Clin Pract. 2011, 17:1153-1159. 10.1111\/j.1365-2753.2010.01494.x","journal-title":"J Eval Clin Pract"},{"key":"ref15","article-title":"Side effects of ropinirole in patients with idiopathic Parkinson's disease","volume":"109","author":"Titlic M","year":"2008","unstructured":"Titlic M, Tonkic A, Jukic I, Lusic I, Dikanovic M. Side effects of ropinirole in patients with idiopathic Parkinson's disease. Bratisl Lek Listy. 2008, 109:273-275.","journal-title":"Bratisl Lek Listy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2005.tb00046.x","article-title":"Ropinirole, a non-ergoline dopamine agonist","volume":"11","author":"Jost WH","year":"2005","unstructured":"Jost WH, Angersbach D. Ropinirole, a non-ergoline dopamine agonist. CNS Drug Rev. 2005, 11:253-272. 10.1111\/j.1527-3458.2005.tb00046.x","journal-title":"CNS Drug Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000120672.94060.f1","article-title":"Ropinirole for restless legs syndrome: a placebo-controlled crossover trial","volume":"62","author":"Adler CH","year":"2004","unstructured":"Adler CH, Hauser RA, Sethi K, Caviness JN, Marlor L, Anderson WM, Hentz JG. Ropinirole for restless legs syndrome: a placebo-controlled crossover trial. Neurology. 2004, 62:1405-1407. 10.1212\/01.wnl.0000120672.94060.f1","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.5.655","article-title":"Ropinirole treatment for restless legs syndrome","volume":"4","author":"Chitnis S","year":"2008","unstructured":"Chitnis S. Ropinirole treatment for restless legs syndrome. Expert Opin Drug Metab Toxicol. 2008, 4:655-664. 10.1517\/17425255.4.5.655","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01588.x","article-title":"The weight of evidence for ropinirole in restless legs syndrome","volume":"13","author":"Trenkwalder C","year":"2006","unstructured":"Trenkwalder C. The weight of evidence for ropinirole in restless legs syndrome. Eur J Neurol. 2006, 13:21-30. 10.1111\/j.1468-1331.2006.01588.x","journal-title":"Eur J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s1353-8020(98)00014-5","article-title":"The impact of ropinirole on blood pressure and noradrenaline concentration after active orthostasis in Parkinsonian patients","volume":"4","author":"Jost WH","year":"1998","unstructured":"Jost WH, Bellon AK, Kaiser T, Schrank B. The impact of ropinirole on blood pressure and noradrenaline concentration after active orthostasis in Parkinsonian patients. Parkinsonism Relat Disord. 1998, 4:61-63. 10.1016\/s1353-8020(98)00014-5","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57488-ropinirole-associated-orthostatic-hypotension-as-cause-of-a-prescribing-cascade-in-an-elderly-man","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:51Z","timestamp":1707507291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57488-ropinirole-associated-orthostatic-hypotension-as-cause-of-a-prescribing-cascade-in-an-elderly-man"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.15506","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}